Akzo's Implanon Seen Getting EUR141M In US (New Ratings)
1006 GMT [Dow Jones] Akzo Nobel's (AKZOY) contraceptive Implanon is valued for the US by F. van Lanschot analyst Geert Jan Hoppers at EUR141M. That's his estimate of profits Akzo can derive from the product in the US over the total life of the product.